Lid Scrub,Thermal Pulsation Treatment And Meibomian Glands Expression To Improve Tears Film Quality And Biometry Accuracy To Adopt Presbyopic Iols Routinely:The Maphry Protocol
Published 2024 - 42nd Congress of the ESCRS
Reference: PO503 | Type: Free paper | DOI: 10.82333/b3xf-wk90
Authors: Barbara Kusa 1 , Matteo Piovella* 1
1Global Center for Ophthalmology,Monza,Italy
Purpose
To evaluate three physical consecutive treatments, Blephex for Lid Scrub(BlephEx, Brentwood TN) LipiFlow (J&J - Santa Ana Ca) ILux (Alcon Fort Worth Texas) for the thermal pulsation treatment of Meibomian Gland Dysfunction(MGD) in vaporative Dry Eye to improve quality of the tears film and of the surface of the cornea to get precise biometry IOLs power calculations useful for presbyopic IOLs wider implantation
Setting
Piovella Global Center for Ophthalmology, Monza, 20900, Monza e Brianza, Italy
Methods
Since 2017, 378 patients (mean age 66.58 ±11.55 years) were treated for MGD. And Evaporative Dry Eye Patients received a LipiFlow treatment to remove obstructions and restore meibomian gland function. 123 of these patients received also Blephex treatment immediately before since September 2019.
65 patients since September 2023 adopted also ILux treatment to complete the MAPHRY protocol based on three physical treatments BlephEx,Lipiflow and Ilux
Results
Postop quality of vision improved in all patients, and regular cornea surface provided more precise and stable biometry results. The adoption of blephex lipiflow and ILux treatments provided 97% of eyes inside the planned refractive postoperative outcome after cataract surgery.
Conclusions
These treatments have a priority role in adopting implants to correct refractive defects and treat presbyopia in cataract patients. They improved precision in detecting the right presbyopic IOL power to avoid postoperative low quality of vision